| Literature DB >> 31076120 |
Jesse D Hinckley1, Paula Riggs2.
Abstract
Substance use disorders (SUDs) are commonly co-occurring among adolescents with depression. Integrated treatment is important given treatment implications and increased rates of suicidality. All adolescents should be screened for SUD using Screening, Brief Intervention, and Referral to Treatment. Review of randomized controlled trials in adolescents reveals motivational enhancement therapy/cognitive behavioral therapy is an evidence-based intervention and should be considered first-line treatment. If depression does not improve, fluoxetine should be considered, as it is well-tolerated in substance-involved adolescents with depression. Adolescents who do not show improvement in SUD or who have severe SUD should be referred to evidence-based SUD treatment.Entities:
Keywords: Adolescents; Co-occurring disorders; Fluoxetine; MET/CBT; Motivational interviewing; SBIRT; Substance use disorders
Mesh:
Substances:
Year: 2019 PMID: 31076120 DOI: 10.1016/j.chc.2019.02.006
Source DB: PubMed Journal: Child Adolesc Psychiatr Clin N Am ISSN: 1056-4993